20/01/2023
Marketing Authorisation Holders (MAHs) are required to monitor scientific and medical literature and to report individual cases of suspected adverse reactions for medicinal products, for which they hold a Marketing Authorisation i
02/01/2023
AxeRegel's team wishes you a wonderful year 2023!We wish you happiness, health and serenity. And more, we wish you a 2023 filled with opportunities, possibilities and, above all, personal well-being and professional dynamism.Make
30/12/2022
The end of the year is here!We would like to thank you for your interest and trust!Our team wishes you a wonderful festive season and remains at your disposal during this period.
23/08/2022
The continued availability of medicines is one of the most important priorities for EU authorities. Indeed, shortages or other problems with the availability of medicinal products create challenges for the medicine supply chain an
11/08/2022
The French National Agency for the Safety of Medicines and Health Products (ANSM) has updated on 08/08/2022 its guidelines for the determination of financial penalties in case of non-compliance of pharmaceutical companies with the